| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.7M | -78.6% |
| SG&A Expense | $3.7M | -12.4% |
| Operating Income | -$5.4M | +55.8% |
| Pre-tax Income | -$5.3M | +56.8% |
| Net Income | -$5.3M | +56.8% |
| EPS (Basic) | -$0.28 | +74.8% |
| EPS (Diluted) | -$0.28 | +74.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | -52.8% |
| Current Assets | $4.2M | -50.2% |
| Total Assets | $4.2M | -50.2% |
| Current Liabilities | $359K | -65.6% |
| Total Liabilities | $359K | -65.6% |
| Stockholders' Equity | $3.8M | -48.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | +57.5% |
| Financing Cash Flow | $1.2M | -74.2% |